BioSig Technologies, Inc. STEX Corporate — Nonoperating Income Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s corporate — nonoperating income expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s corporate — nonoperating income expense?
- BioSig Technologies, Inc. (STEX) reported corporate — nonoperating income expense of -$11.51M in Q1 2026.
- How has BioSig Technologies, Inc.'s corporate — nonoperating income expense changed year-over-year?
- BioSig Technologies, Inc.'s corporate — nonoperating income expense decreased by 6357.1% year-over-year, from $184K to -$11.51M.
- What does corporate — nonoperating income expense mean?
- This metric represents the total net income or expense derived from activities outside of the corporate segment's core business operations. It typically includes interest income, interest expense, investment gains or losses, and other financial items that do not stem from primary revenue-generating activities.